Disparities Details by Sex for 2017
IID-8 : Children receiving the recommended doses of DTaP, polio, MMR, Hib, HepB, varicella and PCV vaccines by age 19–35 months (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Sex for IID-8
IID-8 Increase the percentage of children aged 19 to 35 months who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and pneumococcal conjugate vaccine (PCV)
Children receiving the recommended doses of DTaP, polio, MMR, Hib, HepB, varicella and PCV vaccines by age 19–35 months (percent)
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 71.2%, was attained by the female population.
- The worse group rate for this objective, 69.7%, was attained by the male population.
- The absolute difference (or range) between the best and worst group rates was 1.5 percentage points.
- The best group rate was <1.100 times the worst group rate.
The female population achieved the better group rate for this objective, 71.2%.
The better group rate was <1.1 times the rate for the male population.